Skip to main content

Table 1 Schedule of study

From: Effectiveness and tolerability of repetitive transcranial magnetic stimulation for preventive treatment of episodic migraine: a single-centre, randomised, double-blind, sham-controlled phase 2 trial (Magnet-EM)

Study visit

V1

V2

V3

V4

V5

V6

V7

V8

V9

V10

Check eligibility

X

X

        

Questionnaires

 

X

       

X

Study intervention

  

X

X

X

X

X

   

Randomisation

  

X

       

Laboratory test

  

X

      

X

Headache diary

X

      

X

X

X

AE monitoring

  

X

X

X

X

X

X

X

X

EEG

 

X

       

X

TCD

 

X

       

X

  1. Questionnaires included are MIDAS, EQ-5D, PSQI, MSQv2.1, GPAQ, DASS21, FFQ and satisfaction measures of efficacy, tolerability, safety and expectations of r-TMS. Laboratory tests included are the measurement of serum serotonin level, serum beta-endorphin level and serum CGRP level
  2. AE adverse events, EEG electroencephalography, TCD transcranial Doppler, V visit
Back to article page

Trials

ISSN: 1745-6215